Cell And Gene Therapy Manufacturing

  1. Regulatory Compliance And Viral Vectors 11/13/2023

    Hear from experts who detail the specific regulatory challenges for advanced therapies, as well as how the regulatory requirements differ in early research and development in academia and in industrial vector production.

  2. Collaborating with the FDA: Dr. Peter Marks and Dr. Nicole Verdun Share Advice For Small And Emerging Biotechs 1/30/2024

    In this segment, Dr. Peter Marks and Dr. Nicole Verdun share their advice and best practices for small and emerging biotechs when working with the FDA.

  3. How Past Gene Therapy Approvals Are Shaping the Future with Dr. Peter Marks 1/30/2024

    In this segment of Cell & Gene Live, Dr. Peter Marks shared what he and his team have learned from current gene therapy approvals to accelerate future approvals.

  4. Race To The Regulatory Finish Line: Dr. Nicole Verdun Talks Efficiencies In Platform Technologies 1/30/2024

    Could a platform approach help certain therapies make their way over the regulatory finish line more efficiently?

  5. Dr. Peter Marks on the Adoption of Novel Precision Analytics 1/30/2024

    Hear advice for developers who are worried that the FDA will not accept changes in their process that include a new analytical method.

  6. Breaking Down Automated Manufacturing 8/18/2023

    Experts explain the general benefits of automated manufacturing as well as the key areas that need improvement to scale up quality and to help reduce the costs of therapeutics.

  7. Autoimmune Disease Research's Impact On The Development Of Cell Therapies For Oncology 5/6/2024

    Recently, many cell therapy companies have been pivoting to autoimmune diseases. Expert panelists discuss whether they think there are any learnings or potential headwinds these pivots could provide to cell therapies for oncology.

  8. Achieving Stability For mRNA 1/29/2024

    Expert panelists for this Cell & Gene live event share some of things researchers are exploring to keep mRNA more stable.

  9. An Active Release Mechanism For Magnetic Separation And Cell Isolation 11/13/2023

    Discover an innovative active release solution that will serve autologous and allogeneic processes to the benefit of cell therapy patients.

  10. Technology Needs For Automated Manufacturing 8/18/2023

    Investigate the importance of technology as it relates to automation and standardization within cell therapy manufacturing. The panelists in this discussion cover solutions and services needed for process automation in CGT.